Literature DB >> 9854061

Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.

K Sieradzki1, R B Roberts, D Serur, J Hargrave, A Tomasz.   

Abstract

Methicillin-resistant Staphylococcus epidermidis (MRSE) was recovered over a 2-month period from the dialysis fluid of a peritoneal dialysis (PD) patient who experienced recurrent episodes of peritonitis during therapeutic and prophylactic use of vancomycin. Characterization of five consecutive MRSE isolates by molecular and microbiological methods showed that they were representatives of a single strain, had reduced susceptibility to vancomycin, did not react with DNA probes specific for the enterococcal vanA or vanB gene, and showed characteristics reminiscent of the properties of a recently described vancomycin-resistant laboratory mutant of Staphylococcus aureus. Cultures of these MRSE isolates were heterogeneous: they contained-with a frequency of 10(-4) to 10(-5)-bacteria for which vancomycin MICs were high (25 to 50 microg/ml) which could easily be selected to "take over" the cultures by using vancomycin selection in the laboratory. In contrast, the five consecutive MRSE isolates recovered from the PD patient during virtually continuous vancomycin therapy showed no indication for a similar enrichment of more resistant subpopulations, suggesting the existence of an "occult" infection site in the patient (presumably at the catheter exit site) which was not accessible to the antibiotic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854061      PMCID: PMC84162     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci.

Authors:  A Tomasz; S Nachman; H Leaf
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  Peritonitis due to vancomycin-resistant Staphylococcus epidermidis.

Authors:  D Sanyal; A P Johnson; R C George; B D Cookson; A J Williams
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

3.  Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain.

Authors:  B L de Jonge; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

4.  Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.

Authors:  K Sieradzki; P Villari; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis.

Authors:  D Sanyal; D Greenwood
Journal:  J Med Microbiol       Date:  1993-09       Impact factor: 2.472

6.  Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics.

Authors:  C Chuard; P Vaudaux; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD.

Authors:  D Sanyal; A P Johnson; R C George; R Edwards; D Greenwood
Journal:  J Antimicrob Chemother       Date:  1993-08       Impact factor: 5.790

Review 8.  Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  A von Graevenitz; D Amsterdam
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

9.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus.

Authors:  W C Noble; Z Virani; R G Cree
Journal:  FEMS Microbiol Lett       Date:  1992-06-01       Impact factor: 2.742

10.  THE FINE STRUCTURE OF DIPLOCOCCUS PNEUMONIAE.

Authors:  A TOMASZ; J D JAMIESON; E OTTOLENGHI
Journal:  J Cell Biol       Date:  1964-08       Impact factor: 10.539

View more
  20 in total

1.  In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococci.

Authors:  Peter A Smith; Michael E Powers; Tucker C Roberts; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

Review 2.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

Review 3.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

5.  Cationic Branched Polyethylenimine (BPEI) Disables Antibiotic Resistance in Methicillin-Resistant Staphylococcus epidermidis (MRSE).

Authors:  Anh K Lam; Melissa A Hill; Erika L Moen; Jennifer Pusavat; Cassandra L Wouters; Charles V Rice
Journal:  ChemMedChem       Date:  2018-09-25       Impact factor: 3.466

6.  High Prevalence of Heterogeneously Glycopeptide-Intermediate Coagulase-Negative Staphylococci in Sternal Wounds.

Authors:  Björn Berglund; Carina Claesson; Lennart E Nilsson; Håkan Hanberger
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

7.  Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.

Authors:  S Tevell; C Claesson; B Hellmark; B Söderquist; Å Nilsdotter-Augustinsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-14       Impact factor: 3.267

8.  Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.

Authors:  E Ahlstrand; K Svensson; L Persson; U Tidefelt; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-05       Impact factor: 3.267

9.  Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period.

Authors:  P Villari; C Sarnataro; L Iacuzio
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

10.  Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo.

Authors:  J C Carmen; B L Roeder; J L Nelson; B L Beckstead; C M Runyan; G B Schaalje; R A Robison; W G Pitt
Journal:  J Biomater Appl       Date:  2004-04       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.